GENERAL INFORMATION

Continuum 2024 is sponsored by the International Association of Providers of AIDS Care (IAPAC) in joint providership with PACE. The 2024 conference’s Co-Chairs are Kenneth K. Ngure (Jomo Kenyatta University, Nairobi, Kenya) and Carmen Zorrilla (University of Puerto Rico, San Juan, PR).

The conference Track Chairs:

  • HIV Care Continuum – Julie Levison, Harvard Medical School, Boston, MA, USA
  • HIV Prevention – Rupa Patel, US CDC, Atlanta, GA, USA
  • HIV Treatment – Vanessa Apea, Barts NHS Trust, London, England, UK
  • Implementation Science – Stefan Baral, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
  • Social Determinants of Health – Richard Chilongosi, Family Health Services, Blantyre, Malawi

Following are conference presentations. The conference organizers request that any use of these presentations should include citations to both their presenting authors and relevant conference information (e.g., 19th International Conference on HIV Treatment and Prevention Continuum, June 9-11, 2024).

DISCLOSURE
Continuum 2024 was made possible through commercial sponsorships and educational grants from Gilead Sciences, Merck & Co., and ViiV Healthcare.


SUNDAY, JUNE 9, 2024

PRE-CONFERENCE SESSIONS

Rethinking Acceptability in HIV Care and Prevention
Hosted by Weill Cornell Medicine

Panelists:
Cory Bradley (Northwestern Medicine, Chicago, IL, USA)
Whitney Irie (Boston College School of Social Work, Boston, MA, USA)
Radhika Sundararajan (Weill Cornell Medicine, New York, NY, USA)

 

Fireside Chat with Global HIV Leaders:
Ending AIDS as a Public Health Threat by 2030 and Beyond
Hosted by UNAIDS and IAPAC

Moderator: José M. Zuniga (IAPAC, Tampa, FL, USA)

Panelists:
Angeli Achrekar (Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland) Meg Doherty (World Health Organization, Geneva, Switzerland)
Yogan Pillay (Gates Foundation, Johannesburg, South Africa)

 

WELCOME REMARKS

Kenneth K. Ngure (Jomo Kenyatta University, Nairobi, Kenya)
Carmen Zorrilla (University of Puerto Rico, San Juan, PR)
José M. Zuniga (IAPAC, Tampa, FL, USA)

 

KEYNOTE ADDRESS
Innovation as Catalyst: Paving a Path to HIV Epidemic Control

Yogan Pillay (Gates Foundation, Pretoria, South Africa)

 

HIV CARE CONTINUUM PLENARIES

Moderator: Julie Levison (Harvard Medical School, Boston, MA, USA)

HIV Prevention Innovations: Beyond Traditional Approaches

Mariano Kanamori (University of Miami Miller School of Medicine, Miami, FL, USA)

Engaging and Re-Engaging in HIV Care: Strategies for Success

Thomas P. Giordano (Baylor College of Medicine, Houston, TX, USA)

HIV Care Continuum Optimization: Leveraging Technology

Julian Adong (Mbarara University of Science & Technology, Mbarara, Uganda)

 

IMPLEMENTATION SCIENCE PLENARIES

Moderator: Stefan Baral (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA)

Bridging Gaps: Community-Based Strategies for PrEP Scale-Up

Maggie Chase (USAID, Washington, DC, USA)

Trauma-Informed: Healing Pathways to Enhance HIV Services

Tiara Willie (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA)

Beyond Barriers: Enhancing the Reach of HIV Service Delivery

Thomas Odeny (Kenya Medical Research Institute, Nairobi, Kenya)

 

THREE TOP-RATED ABSTRACTS

Moderators:
Kenneth K. Ngure (Jomo Kenyatta University, Nairobi, Kenya)
Carmen Zorrilla (University of Puerto Rico, San Juan, PR)

1072 Is the United States on Track to Meet National HIV/AIDS Strategy Quality of Life Goals among Black, Hispanic/Latino, and White Men who have Sex with Men?
Linda Beer (US CDC, Atlanta, GA, USA)

1106 Characteristics of and High Acceptance of Daily Oral PrEP and the Dapirivine Vaginal Ring among Adolescent Girls and Young Women seeking Contraception at Retail Pharmacies in Kenya
Felix Mogaka (Kenya Medical Research Institute, Kisumu, Kenya)

1119 A Qualitative Study to Examine HIV-Related Intersectional Stigma, Religion, Spirituality, and ART Adherence among Black Women Living with HIV in Washington, DC
Tamara Taggart (George Washington University, Washington, DC, USA)


MONDAY, JUNE 10, 2024

SPONSORED SATELLITE SYMPOSIUM

PrEP Today: Data Discussions on an HIV-1 PrEP Option
Sponsored by ViiV Healthcare

Speakers:
Robert Morris (ViiV Healthcare, Durham, NC, USA)
Erick Suarez (Pineapple Healthcare, Orlando, FL, USA)
Kimmy C (Patient Ambassador)

 

GARY S. REITER AND ANDREW KAPLAN MEMORIAL LECTURE

Person-Centered HIV Care: Lessons from the Frontlines

Meg Doherty (World Health Organization, Geneva, Switzerland)

 

HIV TREATMENT PLENARIES

Moderator: Vanessa Apea (Barts NHS Trust, London, England, UK)

Innovative Frontiers: Long-Acting ART for Maximum Impact

Christoph Spinner (University Hospital Rechts der Isar, Munich, Germany)

Intersectionality in ART Utilization: A Comprehensive Approach

Zandraetta Tims Cook (Faebris Medical, Atlanta, GA, USA)

Future Horizons: Innovations Shaping the ART Landscape

Moti Ramgopal (Midway Immunology and Research Center, Fort Pierce, FL, USA)

 

ORAL ABSTRACTS SESSIONS 1

Adherence and Engagement Challenges 

1208 Outcomes of Rapid Antiretroviral Therapy (ART) Restart among People with Previously Diagnosed HIV at a Safety-Net HIV Clinic in San Francisco

Jorge Salazar (University of California, San Francisco, Francisco, CA, USA)

1210 Substantial Missingness of Electronic Adherence Monitoring Data in a Randomized Clinical Trial (RCT) of Young Black MSM

Kara Herrera (University of Illinois at Chicago, IL, USA)

1213 Using Electronic Health Records Data to Identify Incarcerated Persons at Increased Risk for HIV Acquisition

Alex Treacher (Parkland Center for Clinical Innovation, Dallas, Texas, USA)

1257 Clinician Perspectives on U=U and Zero HIV Transmission Risk

José M. Zuniga (IAPAC, Tampa, Florida, USA)

1258 Moving Beyond Viral Suppression: Poor Patient-Provider Communication and Its Impact on Overall Health Management Among People Living with HIV in the United States

José M. Zuniga (IAPAC, Tampa, Florida, USA)

 

Experiences with Long-Acting Injectable Therapies

1173 What Matters Most for Long-Acting Antiretroviral Therapy? A Discrete Choice Experiment

Rebecca Fisk-Hoffman (University of Florida, Gainesville, FL, USA)

1207 Early Implementation Experience and Lessons Learned from Eight Diverse Clinics Introducing Long-acting Injectables for HIV Treatment

Kathrine Meyers (Aaron Diamond AIDS Research Center at Columbia University, New York, NY, USA)

1212 Early Implementation and Clinical Outcomes from Real-World Use of Injectable Cabotegravir/Rilpilvarine (iCAB/RPV) at Eight US Clinics Participating in the ALAI UP Project

Nadia Nguyen (Aaron Diamond AIDS Research Center at Columbia University, New York, NY, USA)

1266 Who Could Benefit from Long-Acting Injectable Antiretroviral Therapy? A Qualitative Study Among Florida Providers and People with HIV

Abigail Gracy (University of Florida, Gainesville, Florida, USA)

1291 Understanding the Treatment Experience: A Qualitative Study of Patient Living with HIV who Transitioned from Oral Antiretrovirals to Cabotegravir/Rilpivirine Injectable Therapy

Robert A. Velez (Nova Southeastern University, San Juan, Puerto Rico)

 

HIV and Mental Health

1014 Development and Fidelity Testing of a Brief Suicide Prevention Intervention for People Living with HIV in Kilimanjaro, Tanzania

Brandon Knettel (Duke University, Durham, NC, USA)

1077 Social Determinants of Health Predict HIV Prevention and Care Continua Status among Sexual Minority Men Who Use Methamphetamine

Cathy Reback (Friends Research Institute / UCLA, Los Angeles, CA, USA)

1136 Combing HIV Prevention Options with Mental Health Service Delivery for Adolescent Girls (CHOMA): Results of a Pilot Hybrid Effectiveness-Implementation Randomized Trial

Jennifer Velloza (University of California, San Francisco, San Francisco, CA, USA)

1202 Acceptability and Usefulness of a Relational Agent-Based Mobile Phone App Promoting Healthy Behaviors in Young Black MSM with HIV

Sierra Upton (University of Illinois at Chicago, Chicago, IL, USA)

1203 Screening for Violence Exposures in a Trauma-Informed Manner: Identifying an Optimal Screener for HIV Care Settings

Jessica Sales (Emory University, Rollins School of Public Health, Atlanta, GA, USA)

 

Strategies for PrEP Implementation and Uptake

1098 Implications of PrEP Prescribing Practices on Patient Retention and On-Time Prescriptions

Sarit Golub (Hunter College and Graduate Center of the City University of New York, New York, NY, USA)

1206 A Pilot Randomized Control Trial of Motivational Interviewing to Increase PrEP Uptake (MI-PrEP) among Black Women Placed at Risk for HIV in the US

Sannisha Dale (University of Miami, Miami, FL, USA)

1310 Implementers’ Perspectives and Modifications to Implementation Strategies Used to Increase PrEP Initiation and Persistence Among Cis-Gender Adolescent Girls and Young Women and Female Sex Workers in South Africa: A Sequential Explanatory Mixed Methods Study

Wilson Gomez (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA)

 

SPONSORED LUNCH SYMPOSIUM

Patient and Provider Conversations: Perspectives on a Long-Acting HIV Treatment and Overview of Clinical Data
Sponsored by ViiV Healthcare

Speakers:
Moti Ramgopal (Midway Immunology and Research Center, Fort Pierce, FL, USA)
Turner Overton (ViiV Healthcare, Birmingham, AL, USA)
Orlando (Patient Ambassador)

 

ORAL ABSTRACTS SESSIONS 2

Innovative Approaches and Technologies

1099 Towards Rapid Dapivirine Measurement with a Portable, Low-Cost Platform

Cara Brainerd (University of Washington, Seattle, WA, USA)

Victoria McDonald (University of Alabama at Birmingham, Birmingham, Alabama, USA)

1324 Personnel Identified Barriers and Facilitators to Implementing Trauma-Informed HIV Care for Youth in Southern US

Megan Wilkins (St. Jude Children’s Research Hospital, Memphis, TN, USA)

2009 Effects of Integrated Community-Based Care and Group Microfinance on Antiretroviral Therapy Adherence Among Adults Living with HIV in Western Kenya

Emily O’Neill (St. Jude Children’s Research Hospital, Providence, Rhode Island, USA)

 

HIV Care Engagement Interventions

1018 Effects of a Rideshare Intervention on HIV Care Engagement in South Carolina

Sayward Harrison (University of South Carolina, Columbia, SC, USA)

1117 Impact of a Harm Reduction Program Tailored for Priority Populations who Use Methamphetamine in New York City (NYC)

Justin Knox (Columbia University, New York City, NY, USA) 

1183 New HIV Diagnoses and Community Viral Load During the COVID-19 Pandemic in Washington, DC

Amanda Castel (George Washington University Milken Institute School of Public Health, Washington, DC, USA)

1270 HIV Care Continuum Outcomes in a Cohort of Transgender Women in the United States

Erin Cooney (Johns Hopkins University, Baltimore, MD, USA)

1335 Challenges and Opportunities to Optimize HIV Responses in US Fast-Track Cities

Dashiell Sears (Fast-Track Cities Institute, Washington, DC, USA)

 

PrEP Implementation and Adherence

1121 Utilizing a Stepped Care Approach to Address Substance Use and Increase PrEP Initiation and Adherence among Trans Women and Sexual Minority Men

Cathy Reback (Friends Research Institute / UCLA, Los Angeles, CA, USA)

1126 Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence among Gay, Bisexual, and Other Men Who Have Sex with Men: A Cohort Study in China

Weiming Tang (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)

1200 Engagement with an Interactive Adherence Text Messaging Platform among Women Initiating PrEP during Pregnancy in Kenya: The Mobile WACh-PrEP Study

Salphine Watoyi (Kenyatta National Hospital, Kisumu, Kenya)

1303 Initial Clinical Care Experiences of Men Who Have Sex with Men and Transgender Men who Choose Injectable PrEP in the United States: Results from the PILLAR Study

Heidi Swygard (ViiV Healthcare, Durham, NC, USA)

 

HIV PREVENTION PLENARIES

Moderator: Rupa Patel (US CDC, Atlanta, GA, USA)

Enhanced Outreach: Data-Driven, Equity-Based PrEP Scale-Up

Sten Vermund, Yale School of Public Health, New Haven, CT, USA

Optimized Access: Differentiated Service Delivery for Rapid PrEP

Elzette Rousseau (Desmond Tutu Health Foundation, Cape Town, South Africa)

Building Bridges: Multisector Engagement to Increase Long-Acting PrEP Use

Albert Liu, UCSF-Bay Area CFAR, San Francisco, CA, USA

 

SPONSORED SATELLITE SYMPOSIUM

Treating Virologically Suppressed Patients: Key Study Data
Sponsored by ViiV Healthcare

Presenter: Tulika Singh (UCI Health, Palm Springs, CA, USA)


TUESDAY, JUNE 11, 2024

 

SPONSORED SATELLITE SYMPOSIUM

Transforming HIV Specialty Care Leveraging Retail Pharmacy
Sponsored by Walmart

Speakers:
Aleata Postell (Walmart Specialty Pharmacy, Bentonville, AR, USA)
Katherine Harris (Walmart Specialty Pharmacy, Orlando, FL, USA)

 

MARIO S. COOPER MEMORIAL COLLOQUIUM

Policy Advocacy for PrEP Access: Lessons from the Field

Moderator: Damián Cabrera-Candelaria (NMAC, San Juan, PR)

Presenters:
Noelle Esquire (Elton John AIDS Foundation, Wilmington, NC, USA)
Jeremiah Johnson (PrEP4All, New York, NY, USA)

 

SOCIAL DETERMINANTS OF HEALTH PLENARIES

Moderator: Vinay Saldanha (Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland)

Data-Driven: Geolocating Economic, Food, and Housing Insecurity

Ana Penman-Aguilar (US CDC, Atlanta, GA, USA)

Community-Centered Health: Scaling Up Grassroots Innovation and Building Ecosystems

Karina Maldonado-Mariscal (TU Dortmund University, Dortmund, Germany)

 

ORAL ABSTRACTS SESSIONS 3

HIV Care Strategies and Interventions

1009 Trauma-resilient Research Co-Production in Southern HIV Care Organizations

Lauren Brown (Meharry Medical College, Nashville, Tennessee, USA)

1021 The Association Between Support Services and Linkage to HIV Care Among Persons Newly Diagnosed with HIV by Homelessness and Unstable Housing (HUH)

Jonny Andia (Centers for Disease Control and Prevention, Atlanta, GA, USA)

1032 Improving HIV Viral Load Coverage through Strategic Facility-level Interventions: Best Practices from the USAID-DISCOVER-Health Project

Musonda Musonda (USAID, Lusaka, Zambia)

1204 Strategies for Success: Enhancing Viral Load Suppression among Women with HIV in Puerto Rico

Carmen D. Zorrilla (University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico)

 

PrEP Implementation: Challenges and Solutions

1033 Pregnant, Young and at High(er) Risk of HIV infection: Suboptimal Pre-exposure Prophylaxis Continuation in Pregnant Adolescent Girls and Young Women in Primary level Facilities in Zambia

Musonda Musonda (USAID, Lusaka, Zambia)

1132 Opportunities and Challenges in Reaching Adolescents and Young Adults with PrEP through School Based Health Centers

Kathrine Meyers (Columbia University, New York City, NY, USA)

1170 PrEP Receipt versus PrEP Use among Adolescent Girls and Young Women Offered Peer-Delivered, Community-Based Services in Kisumu, Kenya

Lawrence Ochieng Juma (Kenya Medical Research Institute, Kisimu, Kenya)

1227 Demographic and Behavioral Correlates of PrEP Uptake and Discontinuation Among English and Spanish-Speaking Transgender Women in New York City: The TURNNT Cohort Study

Alexander Furuya (Columbia University, New York City, NY, USA)

 

Social and Behavioral Determinants of Health

1016 Men Interrupted: Strategies to Reduce High Rates of Treatment Interruptions among Men who have Sex with Men (MSM) in South Africa

Dorian Gule (OUT LGBT Well-Being, Johannesburg, South Africa)

1075 Addressing Treatment Interruption among People Living with HIV Using a Systematic Monitoring Tool Piloted in Bacoor City, Philippines

Maria Michella Rabara (EpiC HIV – FHI 360, Makati, Philippines)

1102 National HIV/AIDS Strategy Indicators for HIV Stigma and Quality of Life among People Living with HIV who Inject Drugs in the United States, 2017-2021

Christine Mattson (US CDC, Atlanta, GA, USA)

 

SPONSORED LUNCH SYMPOSIUM

Addressing Critiques of HIV-Related Stigma and Discrimination Measurement: Moving the Science Upstream
Sponsored by NIMH and NIH OAR and Hosted by IAPAC

 

ORAL ABSTRACTS SESSIONS 4

HIV Treatment Adherence Outcomes

1030 Effectiveness of Data-to-Care Activities for Improving HIV Care Outcomes: A Systematic Review

Kristin Roberts (Centers for Disease Control and Prevention, Lilburn, GA, USA)

1199 Misclassification of HIV Care Outcomes in a Population-Representative Sample of People Living with HIV in KwaZulu-Natal Province, South Africa

Lindsey Filiatreau (Washington University in St. Louis, St. Louis, MO, USA)

1308 Predictors of Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda Through 48 Weeks of Follow-Up

Cameron Nutt (Mass General Brigham, Boston, MA, USA)

1315 The Association Between Antiretroviral (ARV) Medication Adherence and Composite Medication Adherence for Non-HIV Chronic Conditions in People with HIV (PWH)

Michael Miller (Mid-Atlantic Permanente Research Institute, Rockville, MD, USA)

1321 Modeling Longitudinal Trajectories of Antiretroviral (ARV) Medication Adherence and Composite Medication Adherence for Non-HIV Chronic Conditions in People with HIV (PWH)

Michael Miller (Mid-Atlantic Permanente Research Institute, Rockville, MD, USA)

 

Policy and Program Evaluation

1078 Medicaid Insurance Expansion and its Association with HIV Outcomes in Nebraska, USA: An Observational Prospective Cohort Study

Emmanuel Nazaire Essam Nkodo (University of Nebraska Medical Center, Omaha, NE, USA)

1092 Anti-Stigmatizing, Client-Centered Sexual History as an Effective Implementation Strategy to Increase EHE Intervention Delivery in Diverse Clinical Settings

Sarit Golub (Hunter College and Graduate Center of the City University of New York, NY, USA) 

1146 Geographic Variations in Real-World Uptake of Oral Pre-Exposure Prophylaxis Prescription Claims in ‘Ending the HIV Epidemic in the United States’ Regions

Li Tao (Gilead Sciences, Foster City, CA, USA)

1153 Best Practices Learned from PEPFAR HRSA Skills Sharing Program in Jamaica

Lauren Richey (Louisiana State University Health Sciences Center, New Orleans, LA, USA)

 

Socio-Contextual Influences on HIV Care

1003 The Other Half: Integrating Qualitative Analyses Across Three Cohorts of Black and Latino Persons Living with HIV Who Are Not HIV Virally Suppressed

Marya Gwadz (New York University, New York, NY, USA)

1110 Contextual Factors Influencing Implementation of HIV Treatment Support Strategies for Female Sex Workers Living with HIV in South Africa: A Qualitative Analysis Using the Consolidated Framework for Implementation Research

Carly Comins (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA)

1112 Implementing Complex HIV Treatment Support Strategies for Female Sex Workers Living with HIV: A Realist-Informed Evaluation

Carly Comins (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA)

1196 Socio-contextual Influences on Time to Viral Suppression in the Deep South: A Qualitative Analysis

D. Scott Batey (Tulane University, New Orleans, LA, USA)

1337 Divergent Perspectives about the Scientific Underpinnings of U=U among PLHIV and HIV-Negative Individuals

Kalvin Pugh (IAPAC, Kansas City, KS, USA)

 

HIGHLIGHTS FROM CONTINUUM 2024

Closing Remarks

Kenneth K. Ngure (Jomo Kenyatta University, Nairobi, Kenya)
Carmen Zorrilla (University of Puerto Rico, San Juan, PR)
José M. Zuniga (IAPAC, Tampa, FL, USA)



					

Our Conferences

Puerto Rico

June 9 - 11, 2024

View Archives

Munich

July 22, 2024

Register

Paris

October 13 - 15, 2024

Register

Virtual

September 15 - 16, 2022

View Archives

Virtual

November 30, 2022 - December 1, 2022

View Archives

Virtual

October 2020 - March 2021

View Archives